Which biomarker tests (RAS, BRAF, MSI) are recommended for my Colorectal Cancer, and how will the results guide my...
Biomarker Testing for Colorectal Cancer: What You Need to Know
I'm glad you're asking about this—understanding your biomarker results is crucial for getting the most effective treatment. Let me walk you through what tests are recommended and how they guide your care.
Which Tests Are Recommended?
According to NCCN Guidelines for Colon Cancer, here are the biomarkers your oncology team should test:
1. RAS Mutations (KRAS and NRAS)
- What it is: A gene mutation that affects how your cancer cells respond to certain drugs
- Who gets tested: All patients with metastatic (stage IV) colorectal cancer
- Sample: Can be done on your primary tumor or metastasis (spread sites)
2. BRAF Mutations
- What it is: Another gene mutation that, like RAS, affects treatment response
- Who gets tested: All patients with metastatic colorectal cancer
- Sample: Tumor tissue or blood-based testing
3. MSI/MMR Status (Microsatellite Instability / Mismatch Repair)
- What it is: A measure of how well your tumor's DNA repair system is working
- Who gets tested: All newly diagnosed colorectal cancer patients (all stages)
- Sample: Tumor tissue analysis
How Results Guide Your Treatment
RAS Mutation Results
If RAS is MUTATED (abnormal):
- ❌ Anti-EGFR drugs like cetuximab or panitumumab will NOT work for you
- ✅ Your doctor will recommend other chemotherapy combinations instead
- Why: The mutation essentially blocks these drugs from being effective
If RAS is WILD-TYPE (normal):
- ✅ Anti-EGFR drugs become an option for your treatment plan
- Your oncologist may combine them with chemotherapy
- This opens up additional treatment pathways
BRAF Mutation Results
If BRAF V600E is MUTATED:
- ❌ Anti-EGFR drugs (cetuximab, panitumumab) are highly unlikely to work
- ⚠️ This is a poor prognostic marker, meaning it suggests more aggressive cancer
- ✅ Better options include:
- BRAF inhibitor combinations (like encorafenib + cetuximab)
- Checkpoint immunotherapy (if MSI-H status is also present)
- Other targeted therapies your doctor will discuss
If BRAF is WILD-TYPE (normal):
- ✅ Opens up more treatment options
- Anti-EGFR drugs may be considered (if RAS is also wild-type)
- Broader range of chemotherapy approaches available
MSI/MMR Status Results
If MSI-HIGH or dMMR (deficient mismatch repair):
- ✅ Checkpoint immunotherapy is often preferred first-line treatment
- Drugs like Keytruda (pembrolizumab) work very well
- This was the first tissue-agnostic biomarker approved by FDA in 2017
- ✅ Better prognosis and response to immunotherapy
- ✅ Stage II MSI-H cancers may have good prognosis without chemotherapy
If MSI-LOW or MSS (microsatellite stable):
- Standard chemotherapy approaches are typically recommended
- Your RAS and BRAF status becomes more important for guiding drug selection
- Immunotherapy alone is less likely to be effective
How Testing Works
According to NCCN Guidelines:
- Testing method: Next-generation sequencing (NGS) is preferred because it can test multiple genes at once
- Sample source: Formalin-fixed paraffin-embedded tissue (FFPE) from your biopsy or surgery
- Timing: Should be done early in your diagnosis to plan your entire treatment strategy
- Certified labs: Testing must be done in CLIA-certified laboratories
Questions to Ask Your Oncologist
Once you have your results, here are specific questions to guide your conversation:
-
"What are my specific RAS, BRAF, and MSI results, and what do they mean for my treatment options?"
-
"Based on my biomarker profile, which treatment approach do you recommend first, and why?"
-
"Are there any clinical trials available that match my specific biomarker results?"
-
"If my first treatment doesn't work, what biomarker-guided options would we consider next?"
-
"Should we repeat biomarker testing if my cancer progresses or after certain treatments?"
Key Takeaway
Your biomarker results are like a "treatment roadmap" for your oncologist. They help determine:
- ✅ Which drugs will likely work for you
- ❌ Which drugs won't be effective (saving you from unnecessary side effects)
- 🎯 Whether immunotherapy, targeted therapy, or chemotherapy is best
- 📊 What your cancer's likely behavior and prognosis might be
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Authoritative Sources Used:
- NCCN Guidelines for Colon Cancer (Version 5.2025) – Principles of Pathologic and Molecular Review
- NCCN Guidelines for Rectal Cancer (Version 4.2025) – Biomarker Testing Recommendations
- CancerPatientLab Webinar: "How MSI and Other Tests Can Guide Immunotherapies for Cancer Treatment" (Heather Tomlinson)
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 16, 2026. Informational only — not a substitute for your oncology team.
Question asked:
Which biomarker tests (RAS, BRAF, MSI) are recommended for my Colorectal Cancer, and how will the results guide my diagnosis and treatment plan?
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with treatment for cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about General
- Some bloating. Could it be colorectal cancer
- Tell me about the Diagnosis confirmed test for Colorectal Cancer. I understand it's used for: Cancer type identified...
- What results should I expect from the CT scan
- What are treatment options for colorectal cancer
- Has anyone had the Signatera test after a breast cancer recurrence? My oncologist said a negative result would be...
- What follow‑up schedule and tests (e.g., imaging, blood work) should I have to monitor for recurrence of Colorectal...
- What tests should I have after a cancer diagnosis
- Given my personal risk factors, what screening tests and frequency are recommended to detect Ovarian Cancer early